Status:
UNKNOWN
Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Oral Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
Detailed Description
The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions
Eligibility Criteria
Inclusion
- oral cancer and oral precancer specimens
Exclusion
- other diseases
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
End Date :
June 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00173316
Start Date
August 1 2004
End Date
June 1 2005
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan university
Taipei, Taiwan, 100